NCT07218328Not yet recruiting
Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families
Source: ClinicalTrials.gov · Last updated 17 Jul 2026
Brief summary (registry, in English)
The goal of this research study is to learn if the FoodiiS-Kids intervention is useful to parents and guardians of pediatric cancer survivors.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- First submitted
- 16 Oct 2025
- Start date
- 30 Dec 2026
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT07218328
What you commit to
- Study type: Interventional
- Planned participants: 21
- From 30 Dec 2026 to the primary completion date, 1 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Parents of pediatric cancer survivors over 12 years of age.
Other
- Unwilling or unable to complete study assessments.
- Self-report to not speak English.
Who the study is looking for
- Parents/guardians of school-aged (5-12 years) pediatric cancer survivors.
- Have children that are within five years of having completed active treatment.
- Self-report having internet access.
- Self-report as being able to speak and read English.
- Willing to complete study assessments.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas M. D. Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.